| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | GBIO | Common Stock | Options Exercise | +1,147 | +0.95% | 122,434 | 15 Oct 2024 | Direct | F1 | ||
| transaction | GBIO | Common Stock | Tax liability | $816 | -337 | -0.28% | $2.42 | 122,097 | 15 Oct 2024 | Direct |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | GBIO | Restricted Stock Units | Options Exercise | $0 | -1,147 | -10% | $0.000000 | 10,317 | 15 Oct 2024 | Common Stock | 1,147 | Direct | F1, F2 |
| Id | Content |
|---|---|
| F1 | Each restricted stock unit represents the right to receive one share of the company's common stock. |
| F2 | On January 20, 2023, the reporting person was granted 18,345 restricted stock units. The shares underlying the restricted stock units vest over four years, with 25% of the shares vested on January 15, 2024 and the remaining shares vesting in equal quarterly installments thereafter. |